Trifluoroacetic acid → Quinoxaline-6-carboxylic acid 3-phenoxybenzylamide
反応式
[N:1]1[C:10]2[C:5](=[CH:6][C:7]([C:11]([OH:13])=O)=[CH:8][CH:9]=2)[N:4]=[CH:3][CH:2]=1.[O:14]([C:21]1[CH:28]=[CH:27][C:24](CN)=[CH:23][CH:22]=1)[C:15]1[CH:20]=[CH:19][CH:18]=[CH:17][CH:16]=1.[N:29]1C=CC=C[C:30]=1OCC1C=CC(CNC(C2C(N)=NC(N)=CN=2)=O)=CC=1.F[P-](F)(F)(F)(F)F.N1(O[P+](N2CCCC2)(N2CCCC2)N2CCCC2)C2C=CC=CC=2N=N1.C(N(CC)CC)C.FC(F)(F)C(O)=O>CN(C)C=O>[O:14]([C:15]1[CH:16]=[C:17]([CH:18]=[CH:19][CH:20]=1)[CH2:30][NH:29][C:11]([C:7]1[CH:6]=[C:5]2[C:10](=[CH:9][CH:8]=1)[N:1]=[CH:2][CH:3]=[N:4]2)=[O:13])[C:21]1[CH:22]=[CH:23][CH:24]=[CH:27][CH:28]=1参加物
8
実験手順
To a solution of quinoxaline-6-carboxylic acid described in Preparation Example I-1 (15 mg, 0.063 mmol) and 4-phenoxybenzylamine described in Preparation Example 3 (13 mg, 0.063 mmol) in N,N-dimethylformamide (2 mL) were added benzotriazol-1-yloxytris(pyrrolidino)phosphonium hexafluorophosphate (36 mg, 0.069 mmol) and triethylamine (19 μl, 0.14 mmol), which was then stirred at room temperature for 24 hours. The reaction mixture was concentrated, the residue was purified by reverse phase high performance liquid chromatography (acetonitrile-water mobile phase (containing 0.1% trifluoroacetic acid) was used), and the title compound (12 mg, 0.025 mmol, 40%) was obtained as a trifluoroacetic acid salt.
後処理
- concentrationThe reaction mixture was concentrated
- customthe residue was purified by reverse phase high performance liquid chromatography (acetonitrile-water mobile phase (containing 0.1% trifluoroacetic acid) was used)
出典と根拠
- ORDレコード
- ord-c97b1c525ab94f2989d87a0777c7da3e
- 出典データセット
- uspto-grants-2011_04
- 特許番号
- US07932272B2
反応ノート
読み込み中…